PI(16:0/22:4(10Z,13Z,16Z,19Z))

Metabolite details

Identifier

PSFLOZGKTVHJEH-HACPKTPBSA-N

InChI Key

PSFLOZGKTVHJEH-HACPKTPBSA-N

IUPAC name

Preferred name

PI(16:0/22:4(10Z,13Z,16Z,19Z))

INN name

—

Synonym

[(2R)-2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyloxy]-3-(hexadecanoyloxy)propoxy]({[(1s,3R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid

ChEBI

CHEBI:88421

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
• A multi-omics approach to study peroxisome proliferator-activated receptor mediated regulation of lipid metabolism in Atlantic cod (Gadus morhua)
• Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
• LION-web validation lipidomics experiments (FA-incorporation, membrane fluidty)

Observed in differential profiles

• non_COVID_19_healthy_vs_non_critical_COVID_19
• Control_Plasma_vs_WY-14,643_Plasma
• Normal_control_no_tumor_vs_FH_deficient_RCC
• BSA_Control_vs_AA